Skip to content
HealthMinute.TV

HealthMinute.TV

  • Home
  • Derm.City
  • Derm.Business
  • Chronicle Companies
  • Contact

Category: psoriasis

March 6, 2025 chroniclepublishing psoriasis

Study shows induction therapy with ixekizumab may lower drug survival

According to a recent study, induction therapy with ixekizumab in patients with moderate-to-severe plaque psoriasis may offer faster symptom relief but shows lower long-term drug survival.

February 27, 2025 chroniclepublishing psoriasis

Recent study suggests plant-rich diets with low saturated fats may be associated with reduced PsO severity

According to a recent study, healthier eating patterns may be linked to psoriasis severity.

February 19, 2025February 16, 2025 chroniclepublishing psoriasis

Oral roflumilast efficacious in treating moderate-to-severe plaque PsO

According to a recent real-world study, oral roflumilast was efficacious in reducing disease severity in moderate-to-severe plaque psoriasis.

January 22, 2025January 23, 2025 chroniclepublishing psoriasis

Inflammation may be linked to stomach problems in psoriasis patients

According to a recent study, inflammation in psoriasis patients may be tied to stomach problems.

October 16, 2024October 17, 2024 chroniclepublishing psoriasis

New study links stress and psoriasis relapse

According to a recent study, perceived stress can trigger the relapse of psoriatic skin lesions. The study was presented at the European Academy of Dermatology and Venereology Congress in Amsterdam (Sept. 27, 2024).

October 10, 2024 chroniclepublishing psoriasis

Home-based narrowband UV-B phototherapy for PsO as effective as office-based treatment

According to a recent study, home-based narrowband UV-B phototherapy for plaque and guttate psoriasis is as effective as office-based treatments.

September 25, 2024September 26, 2024 chroniclepublishing psoriasis

Veterans are more at risk for psoriasis, skin cancer

According to a recent study, U.S. veterans are more likely to have a history of skin cancer, melanoma, and psoriasis when compared to non-veterans.

September 12, 2024 chroniclepublishing psoriasis

Extended guselkumab dosing effective for PsO super responders

According to a recent study, extending the dosing interval of guselkumab from eight weeks to sixteen weeks is non-inferior for treating moderate-to-severe psoriasis in super-responders.

August 29, 2024 chroniclepublishing psoriasis

PsO disease severity linked to missed work days

According to a recent study, patients with moderate-to-severe psoriasis are more than twice as likely to take a half-day off work than those with mild psoriasis.

August 14, 2024August 11, 2024 chroniclepublishing psoriasis

Study suggests significant autoimmune disease prevalence in PsO patients

According to a recent study, there is a significant autoimmune disease prevalence in psoriasis patients. 

Posts navigation

Older posts
Newer posts
Create a website or blog at WordPress.com
HealthMinute.TV
Create a website or blog at WordPress.com
Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookie Policy
  • Subscribe Subscribed
    • HealthMinute.TV
    • Join 63 other subscribers
    • Already have a WordPress.com account? Log in now.
    • HealthMinute.TV
    • Subscribe Subscribed
    • Sign up
    • Log in
    • Report this content
    • View site in Reader
    • Manage subscriptions
    • Collapse this bar
Loading Comments...
Design a site like this with WordPress.com
Get started